St. Louis vaccine startup snags $3.6M. It expects more funding is on the way.


A St. Louis startup developing vaccines has snagged $3.6 million in federal funding. That comes as its also seeking out private investors to drive growth.

Previous Oracle Cerner's Learning Health Network could hasten new cancer treatments
Next HCA launches $15 million collaboration with the American Heart Association